<scp>BRAF</scp> and <scp>MEK</scp> inhibitor combinations induce potent molecular and immunological effects in <scp>NRAS</scp>‐mutant melanoma cells: Insights into mode of action and resistance mechanisms

Lisa Dinter(German Cancer Research Center), Dana Westphal(German Cancer Research Center)
International Journal of Cancer
December 11, 2023
Cited by 13


Related Papers